COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions
Authors:
Open Access
- 27 April 2021
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
Abstract
A state of hyperinflammation and increased complement activation has been associated with coronavirus disease 2019 (COVID-19) severity. However, the pathophysiological mechanisms that contribute to this phenomenon remain mostly unknown.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK123733)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (R24 AA026801)
- foundation for AIDS Research (109840-65-RGR)
- HHS | National Institutes of Health (R01 AG062383)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS117458)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R21 AI143385)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R21 AI129636)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (P30 AI 045008)
This publication has 15 references indexed in Scilit:
- Mild or Moderate Covid-19New England Journal of Medicine, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Complement as a target in COVID-19?Nature Reviews Immunology, 2020
- Coronaviruses hijack the complement systemNature Reviews Immunology, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus PathogenesismBio, 2018
- Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIVJournal of Immunological Methods, 2018
- Beyond binding: antibody effector functions in infectious diseasesNature Reviews Immunology, 2017